The updated label with additional data reinforces the safety and efficacy profile of Biktarvy to treat pregnant people with HIV-1 with suppressed viral loads, the company said.
In his first remarks as NACDS chair, Kevin Host talked next generation of pharmacies, and diverse NACDS members’ role in revolutionizing the way people receive care.